Xiaozhi Wang

1.5k total citations
52 papers, 1.1k citations indexed

About

Xiaozhi Wang is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Xiaozhi Wang has authored 52 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 18 papers in Pulmonary and Respiratory Medicine and 15 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Xiaozhi Wang's work include Sepsis Diagnosis and Treatment (17 papers), Trauma, Hemostasis, Coagulopathy, Resuscitation (9 papers) and Respiratory Support and Mechanisms (8 papers). Xiaozhi Wang is often cited by papers focused on Sepsis Diagnosis and Treatment (17 papers), Trauma, Hemostasis, Coagulopathy, Resuscitation (9 papers) and Respiratory Support and Mechanisms (8 papers). Xiaozhi Wang collaborates with scholars based in China, United States and United Kingdom. Xiaozhi Wang's co-authors include Changjun Lv, Xiao Huang, Xiangyong Liu, Hao Dong, Guohong Cao, Weiwei Zhu, Jinjin Zhang, Xiaodong Song, Weili Liu and Meirong Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Xiaozhi Wang

49 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaozhi Wang China 21 336 298 283 220 214 52 1.1k
Weihua Lü China 16 298 0.9× 250 0.8× 273 1.0× 81 0.4× 213 1.0× 49 1.0k
Mei Xue China 21 402 1.2× 219 0.7× 109 0.4× 47 0.2× 91 0.4× 82 1.4k
Haibo Zhang China 21 228 0.7× 414 1.4× 234 0.8× 117 0.5× 87 0.4× 118 1.4k
Haifa Xia China 19 226 0.7× 113 0.4× 207 0.7× 86 0.4× 74 0.3× 40 807
Chiara Mozzini Italy 19 348 1.0× 166 0.6× 169 0.6× 40 0.2× 106 0.5× 47 1.2k
Dorel Săndesc Romania 16 172 0.5× 164 0.6× 74 0.3× 116 0.5× 64 0.3× 85 946
Andreas Hecker Germany 23 350 1.0× 276 0.9× 437 1.5× 41 0.2× 133 0.6× 106 1.5k
Sang Hyun Kwak South Korea 18 224 0.7× 160 0.5× 200 0.7× 39 0.2× 98 0.5× 65 876
Yingbin Xiao China 16 291 0.9× 180 0.6× 94 0.3× 163 0.7× 68 0.3× 43 916
Jan Eritsland Norway 27 243 0.7× 216 0.7× 134 0.5× 64 0.3× 53 0.2× 81 2.0k

Countries citing papers authored by Xiaozhi Wang

Since Specialization
Citations

This map shows the geographic impact of Xiaozhi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaozhi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaozhi Wang more than expected).

Fields of papers citing papers by Xiaozhi Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaozhi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaozhi Wang. The network helps show where Xiaozhi Wang may publish in the future.

Co-authorship network of co-authors of Xiaozhi Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaozhi Wang. A scholar is included among the top collaborators of Xiaozhi Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaozhi Wang. Xiaozhi Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Xiao Ru, et al.. (2025). S100A9 in sepsis: A biomarker for inflammation and a mediator of organ damage. Biochemical and Biophysical Research Communications. 752. 151484–151484. 1 indexed citations
2.
Huang, Xiao, et al.. (2024). MiR-625-5p is a potential therapeutic target in sepsis by regulating CXCL16/CXCR6 axis and endothelial barrier. International Immunopharmacology. 137. 112508–112508.
3.
Wang, Xiaozhi, Huaqing Liu, Qing Su, et al.. (2024). Unraveling EGFR-TKI resistance in lung cancer with high PD-L1 or TMB in EGFR-sensitive mutations. Respiratory Research. 25(1). 40–40. 8 indexed citations
4.
Huang, Xiao, et al.. (2024). NETs induce ferroptosis of endothelial cells in LPS-ALI through SDC-1/HS and downstream pathways. Biomedicine & Pharmacotherapy. 175. 116621–116621. 24 indexed citations
5.
Huang, Xiao, Haoran Hu, Hao Dong, et al.. (2022). Association between plasma glycocalyx component levels and poor prognosis in severe influenza type A (H1N1). Scientific Reports. 12(1). 163–163. 9 indexed citations
7.
Pan, Lei, Jun‐Hong Yan, Hong Li, et al.. (2019). Case report of a 28-year-old man with aortic dissection and pulmonary shadow due to granulomatosis with polyangiitis. BMC Pulmonary Medicine. 19(1). 122–122. 7 indexed citations
8.
Li, Quan, et al.. (2019). Carcinoma ex pleomorphic adenoma of the trachea: A case report. World Journal of Clinical Cases. 7(17). 2623–2629. 3 indexed citations
9.
Yang, Yang, Jie Zhao, Hao Dong, et al.. (2019). Increased SPK1 expression promotes cell growth by activating the ERK1/2 signaling in non-small-cell lung cancer. Anti-Cancer Drugs. 30(5). 458–465. 2 indexed citations
10.
Zhang, Dong, Dongxiao Li, Jiali Feng, et al.. (2019). Phillyrin Relieves Lipopolysaccharide-Induced AKI by Protecting Against Glycocalyx Damage and Inhibiting Inflammatory Responses. Inflammation. 43(2). 540–551. 32 indexed citations
11.
Yu, Xiangyou, Tongwen Sun, Yanfen Chai, et al.. (2018). ADJunctive Ulinastatin in Sepsis Treatment in China (ADJUST study): study protocol for a randomized controlled trial. Trials. 19(1). 133–133. 11 indexed citations
12.
Huang, Lina, Xiaohua Zhang, Xiaohong Ma, et al.. (2018). Berberine alleviates endothelial glycocalyx degradation and promotes glycocalyx restoration in LPS-induced ARDS. International Immunopharmacology. 65. 96–107. 46 indexed citations
13.
Liu, Xiaoli, Xiaozhi Wang, Tao Wang, et al.. (2017). Epidemic hemorrhagic fever complicated with late pregnancy. Medicine. 96(40). e8137–e8137. 2 indexed citations
14.
Wang, Lipeng, Xiao Huang, Jiankui Li, et al.. (2016). Ulinastatin attenuates pulmonary endothelial glycocalyx damage and inhibits endothelial heparanase activity in LPS-induced ARDS. Biochemical and Biophysical Research Communications. 478(2). 669–675. 45 indexed citations
15.
Yin, Xue, Xiuli Zhang, Changjun Lv, et al.. (2015). Protocatechuic acid ameliorates neurocognitive functions impairment induced by chronic intermittent hypoxia. Scientific Reports. 5(1). 14507–14507. 54 indexed citations
16.
Ma, Mingming, Yan Li, Xiangyong Liu, et al.. (2015). Cyanidin-3-O-Glucoside Ameliorates Lipopolysaccharide-Induced Injury Both In Vivo and In Vitro Suppression of NF-κB and MAPK Pathways. Inflammation. 38(4). 1669–1682. 60 indexed citations
17.
Lv, Changjun, Xiangyong Liu, Hao Dong, et al.. (2013). Genome-wide analysis of DNA methylation in rat lungs with lipopolysaccharide-induced acute lung injury. Molecular Medicine Reports. 7(5). 1417–1424. 28 indexed citations
18.
19.
Han, Shasha, et al.. (2011). [Effect of continuous blood purification on endothelial cell function in patients with severe sepsis].. PubMed. 23(2). 81–4. 5 indexed citations
20.
Liu, Xiaoli, et al.. (2009). Low-dose heparin on treatment of sepsis in hypercoagulable period. Chinese Journal of Asthma. 29(15). 917–919. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026